Do patients with prosthetic heart valves who develop infective endocarditis require valve replacement?

Prosthetic Valve Endocarditis Does Not Always Require Valve Replacement

Routine surgery is NOT indicated for patients with uncomplicated prosthetic valve endocarditis caused by first infection with a sensitive organism 1. However, surgical consultation should be obtained in ALL cases of prosthetic valve endocarditis 1, 2, 1.

When Surgery IS Indicated (Class I Recommendations)

Surgery is mandatory for prosthetic valve endocarditis patients presenting with:

• Heart failure 1, 2, 1, 2
• Prosthetic valve dehiscence (evidenced by cine fluoroscopy or echocardiography) 1, 2, 1, 2
• Increasing obstruction or worsening regurgitation 1, 2, 1, 2
• Complications such as abscess formation 1, 2, 1, 2

When Surgery is Reasonable (Class IIa Recommendations)

Surgery should be strongly considered for:

• Persistent bacteremia despite appropriate antibiotics 1
• Recurrent emboli despite appropriate antibiotic treatment 1
• Relapsing infection 1

The Critical Distinction: Complicated vs. Uncomplicated PVE

The 2014 AHA/ACC guidelines emphasize that surgical debridement and replacement of infected prosthetic valves leads to significantly lower mortality (23%) compared with medical therapy alone (56%) 3. However, this applies primarily to complicated cases. In a large series of 1,025 PVE patients, those with the strongest surgical indications (new left-sided valve regurgitation, paravalvular abscess or fistula, prosthetic valve dehiscence, or heart failure) had lower 1-year mortality with early surgery (27.9% versus 50.0%) 3.

Organism-Specific Considerations

Early surgery during initial hospitalization is indicated for highly resistant organisms including:

• S. aureus 3
• Fungal infections 3
• Other highly resistant organisms 3

The mortality data strongly supports this: PVE has higher mortality rates especially when the infectious microbe is staphylococcal or fungal 3.

Common Pitfalls to Avoid

1. Don't delay surgical consultation: Even if medical management is initially chosen, cardiac surgery should be involved from diagnosis 1, 2, 1, 4

2. Don't assume all PVE needs immediate surgery: Stable patients with sensitive organisms (particularly streptococci), no structural damage, and no cardiac complications can be managed medically with close monitoring 1

3. Don't ignore timing: Most surgical series report nearly 50% of PVE patients ultimately require surgery, and up to 20% more would benefit if not for already-developed catastrophic complications 3

The Practical Algorithm

Step 1: Obtain surgical consultation immediately upon PVE diagnosis

Step 2: Assess for Class I surgical indications (heart failure, dehiscence, obstruction/regurgitation, abscess)

• If present → Proceed to surgery

Step 3: If no Class I indications, evaluate organism and response to therapy

• S. aureus, fungal, or highly resistant organism → Early surgery indicated 3
• Sensitive organism (e.g., streptococci) + stable hemodynamics + no structural damage → Medical management with close monitoring

Step 4: Monitor for Class IIa indications (persistent bacteremia, recurrent emboli, relapsing infection)

• If develop → Proceed to surgery

Step 5: Reassess surgical candidacy if clinical status changes

The evidence demonstrates that approximately 50% of PVE patients ultimately require surgery 3, but the decision must be individualized based on hemodynamic stability, organism virulence, structural complications, and response to antibiotics. The key is early surgical consultation and vigilant monitoring for indications that mandate operative intervention.